P3 Health Partners Inc reports results for the quarter ended June 30 - Earnings Summary

P3 Health Partners

10/08/2026 22:43

P3 Health Partners Inc PIII.OQ reported a quarterly adjusted loss of 63 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-6.23.  The mean expectation of two analysts for the quarter was for a loss of $1.89 per share. Wall Street expected results to range from $-2.10 to $-1.69 per share.
Revenue rose 8.6% to $386.38 million from a year ago; analysts expected $377.95 million. 
P3 Health Partners Inc's reported EPS for the quarter was a loss of 63 cents​.
The company reported a quarterly loss of $2.13 million.
P3 Health Partners Inc shares had risen by 7.2% this quarter and gained 231.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 29.9% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for P3 Health Partners Inc is $14.00, about 17.3% above its last closing price of $11.58
This summary was machine generated from LSEG data August 10 at 09:43 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-1.89
-0.63
Beat
Mar. 31 2026 
-3.50
0.32
Beat
Dec. 31 2025 
-9.46
-23.02
Missed
Sep. 30 2025 
-6.04
-9.67
Missed